Current Research Studies

FH9716 Phase I study of adoptive immunotherapy with CD8+ and CD4+ memory T cells transduced to express an HA-1-specific T cell receptor (TCR) for children and adults with recurrent acute leukemia after allogeneic hematopoietic stem cell transplantation (HCT).

RG9217022 FH 9716

  • Condition(s): Leukemia, other, Lymphoid Leukemia, Myeloid and Monocytic Leukemia
  • Phase: I
  • Clinicaltrials.gov ID: NCT03326921

What is the goal of the study?

To evaluate the feasibility and safety of administration of HA-1 TCR T cell immunotherapy to children and adults with recurrent acute leukemia after allogeneic HCT

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

  • PI (Study Doctor): Elizabeth Krakow
  • Study Team Member: Elizabeth Frecker, [email protected]